09.24.25 -- RFK Jr. Wants Every American Wearing A Wearable. How Can Pharma Build A Business Around It?

Discover how mobile visits are transforming clinical trials by reducing barriers to participation, enhancing diversity, and bringing studies closer to patients and their communities.

Explore what your organization should consider when selecting a digital health partner and monitoring solutions for your clinical trial.

Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.

Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.

By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.

While GLP-1 receptor agonists offer significant health benefits, proactive eye care and vigilance are essential to mitigate the risk of irreversible ocular conditions.

In 2024, the number of industry-sponsored clinical trials reaching completion accelerated significantly. Explore the trial counts and rankings, top 5 diseases for trials, and more.

Live biotherapeutic products (LBPs) are emerging as a dynamic area of drug development, and their development demands tailored strategies that address both manufacturing and nonclinical complexities.

In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.